Dr. Paola Sandroni, MD

Dr. Sandroni practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Sandroni's NPI, 1841279494, was assigned on January 12, 2006. Dr. Sandroni graduated from University of Milan Faculty of Medicine in 1986. Dr. Sandroni holds Minnesota license 38321.

Dr. Sandroni's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Sandroni's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Sandroni is also affiliated with Mayo Clinic Health System in Mankato. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Sandroni to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sandroni practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sandroni's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sandroni is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Sandroni's licenses on file in 8 states: Minnesota, Arizona, Florida, North Dakota, Connecticut, Oklahoma, Tennessee and Alaska.

Dmand AI lists essential tremor, hereditary polyneuropathy, lower back pain, mobility impairment and neuropathy among the conditions Dr. Sandroni treats.

CMS data shows 348 Medicare services from Dr. Sandroni across 8 procedure codes in 2024, for 240 Medicare patients. Medicare paid $37,088 for them.

CMS counts 240 Medicare patients who saw Dr. Sandroni in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sandroni's median patient age at 53, with 61% women.

In 2024, Dr. Sandroni wrote 176 Medicare Part D claims for 50 patients. 98% of them were for generic drugs. CMS names the drug for 124 of them, across 7 drugs with 11 or more claims each, at $3,284 in total drug cost. In 2023, CMS named 102 claims across 5 drugs.

Dr. Sandroni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sandroni as offering telehealth.

Dmand AI links 136 papers to Dr. Sandroni, published from 2004 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Autonomic Nervous System Diseases, Multiple System Atrophy and Blood Pressure. Dr. Sandroni has published most often in Neurology. Dr. Sandroni's most frequent co-authors are Elizabeth A. Coon, MD, Robert D. Fealey, MD and Wolfgang Singer, MD.

CMS Open Payments shows 20 general payments to Dr. Sandroni from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Pfizer Inc. paid the most, $3,990. It also lists 5 research payments totaling $6,190 from 2020 to 2021.

Dr. Sandroni graduated from University of Milan Faculty of Medicine in 1986. Dr. Sandroni is a member of AAN.

Dr. Sandroni is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.